Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEK (MAP2K)-Tunlametinib
Tunlametinib

Chemical Structure : Tunlametinib

CAS No.: 1801756-06-8

Tunlametinib (HL-085, HL085)

Catalog No.: PC-38424Not For Human Use, Lab Use Only.

Tunlametinib (HL-085) is a highly selective and potent MEK inhibitor with IC50 of 1.9 nM (MEK1), exhibits potent activity against RAS/RAF mutant cancer cells.

Packing Price Stock Quantity
5 mg $488 In stock
10 mg $758 In stock
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Tunlametinib (HL-085) is a highly selective and potent MEK inhibitor with IC50 of 1.9 nM (MEK1), exhibits potent activity against RAS/RAF mutant cancer cells.
Tunlametinib (HL-085) exhibits approximately 19-fold greater inhibitory activity against MEK1/MAP2K1(h) kinase than the lead compound MEK162.
Tunlametinib (HL-085) at 10 μmol/L shows complete inhibition against MEK1 and no inhibition against other 77 kinases tested.
Tunlametinib (HL-085) dramatically inhibits cell proliferation in a panel of cell lines with RAS or RAF mutation, with IC50 values of 0.67 and 59.89 nM, with minimal inhibitory effect on the proliferation of RAS/RAF wild-type tumor cells (H1975) and normal cells (MRC-5)
Tunlametinib (HL-085) is more effective for RAS/RAF-mutant cell lines with improved potency compared to AZD6244.
Tunlametinib (HL-085) potently inhibits ERK phosphorylation in A375 cells with IC50 of 1.16 nM.
Tunlametinib (HL-085) could dose-dependently increase the proportion of G0/G1 phase in A375 cells at concentration from 1 nM to 9 nM.
Tunlametinib (HL-085) (1, 3, 6 mg/kg, QD) inhibits tumor growth of cell line-derived xenografts (CDXs) or patient derived CRC xenograft (PDX).
Tunlametinib (HL-085) combined with BRAF/KRASG12C/SHP2 inhibitors or docetaxel showed synergistically enhanced response and marked tumor inhibition.

Physicochemical Properties

M.Wt 491.251
Formula C16H12F2IN3O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)benzo[d]thiazole-6-carboxamide

References

1. Patent WO2013107283 A1.
2. Liu Y, et al. Front Pharmacol. 2023 Sep 21;14:1271268.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: